Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Crospon takes EndoFLIP into US with €2m

This article was originally published in Clinica

Executive Summary

Irish medical device developer Crospon is preparing for the US launch of its flagship product, the EndoFLIP gastro-diagnostic imaging device, after receiving 510(k) clearance and raising €2m ($2.9m) in additional funding. The financing came from Crospon’s existing shareholders – a number of private investors and Enterprise Ireland – as well as new investor The Wellcome Trust. The funds and FDA clearance will enable Galway-based Crospon to begin commercialisation activities in the US – through its Carlsbad, California subsidiary established last year – and build up clinical data to support the use of EndoFLIP for wider indications, particularly within bariatric surgery. The EndoFLIP (which stands for endolumenal functional lumen imaging probe) is used to measure the dimensions and function of various hollow organs and sphincters throughout the gastrointestinal tract. Its first indication is for use as a tool to aid diagnosis of gastroesophageal reflux disease (GERD), but can also have wider applications such as in bariatric surgery and diagnosing anorectal disorders.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT045202

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel